USD10
PRQR Shares
About ProQR TherapeuticsProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
USD10
PRQR Shares
About ProQR TherapeuticsProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$239.91M
OPEN PRICE
$1.67
LOW (1Y)
$1.33
HIGH (1Y)
$3.10
LOW (24H)
$1.62
HIGH (24H)
$1.76
VOLUME (24H)
$676.77K
12.45%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.67 | |
1 Day | $1.70 | 0.00% |
1 Week | $1.73 | |
1 Month | $1.77 | |
1 Year | $2.34 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.